An Analysis of the Relationship between Factors Causing Multi-Drug Resistant Tuberculosis (Mdr-Tb) in the Minahasa Regency Area
DOI:
https://doi.org/10.35960/vm.v17i2.1500Keywords:
Minahasa, Multi-drug, Resistant, TuberculosisAbstract
The World Health Organization (WHO) estimates that only 8.5% of multidrug-resistant tuberculosis (MDR-TB) is successfully treated. This study analyzes the factors contributing to Multi-Drug Tuberculosis Resistance in Minahasa Regency. This research uses mixed methods that combine quantitative and qualitative methods. Quantitative data uses a cross-sectional study approach, while qualitative in-depth interview data is the basis for strengthening quantitative data. The research was conducted from April to May 2024 in three districts in Minahasa: Tompaso, Kawangkoan, and Langowan. This study involved 111 respondents (94 people with pulmonary TB and 17 people with MDR-TB) and six key informants (4 from the patient's family and two health workers). The results showed that the incidence of MDR-TB in TB sufferers was significantly related to age ≤40 years (p=0.016), marital status (p=0.011), and adherence to taking medication (p=0.000). Multivariate analysis showed a significant relationship simultaneously between age, marital status, and medication adherence and the incidence of MDR-TB, with a p-value of 0.000 (OR 5.529). These results were strengthened by key informants who explained that sufferers experienced difficulties in complying with treatment due to complaints of OAT side effects and the large variety of drugs. In conclusion, there is a significant relationship between age, marital status, adherence to taking medication, and the incidence of MDR TB in Minahasa Regency
References
Abbas, A. (2017). Monitoring Efek Samping Obat Anti-Tuberkulosis (OAT) Pada Pengobatan Tahap Intensif Penderita TB Paru Di Kota Makassar. Journal of Agromedicine and Medical Sciences, 3(1), 20–24.
Absor, S., Nurida, A., Levani, Y., & Nerly, W. S. (2020). Hubungan Tingkat Pendidikan Dengan Kepatuhan Berobat Penderita Tb Paru Di Wilayah Kabupaten Lamongan Pada Januari 2016 – Desember 2018. Medica Arteriana (Med-Art), 2(2), 80. https://doi.org/10.26714/medart.2.2.2020.80-87
Al Qarni Bayan, U. (2022). Karakteristik Pasien Tuberkulosis Resistan Obat di Rsud Dr. H. Chasan Boesoirie. Kieraha Medical Journal, 4(2), 116–123. https://doi.org/10.33387/kmj.v4i2.4651
Alveryna, D., Nilapsari, R., & Rahmi, D. (2020). Perbedaan Kejadian TB MDR dengan TB Non MDR Berdasarkan Karakteristiknya di RS Paru Dr . H . A Rotinsulu. Prosiding Kedokteran, 6, 194–200.
Amalia, A., Arini, H. D., & Dhrik, M. (2022). Analysis of The Relationship of Compliance Rate of Antituberculosis Drug on The Quality of Life of Lung Tuberculosis Patients. Jurnal Ilmiah Mahaganesha, 1(2), 67–74.
Depo, M., & Pademme, D. (2022). Faktor yang berhubungan dengan kepatuhan berobat penderita tuberkulosis paru di kota Sorong. Jurnal Teknosains, 11(2), 174. https://doi.org/10.22146/teknosains.61225
Octaviani, P., & Kusuma, I. Y. (2018). Studi Pengaruh Status Perkawinan dan Pekerjaan Penyakit tuberkulosis sudah dicanangkan oleh WHO ( World Health Organization ) sebagai Global Emergency sejak tahun. Viva Medika, 46–51.
Papeo, D. R. P., Immaculata, M., & Rukmawati, I. (2021). Hubungan Antara Kepatuhan Minum Obat (MMAS-8) Dan Kualitas Hidup (WHOQOL-BREF) Penderita Tuberkulosis Di Puskesmas Di Kota Bandung. Indonesian Journal of Pharmaceutical Education, 1(2), 86–97. https://doi.org/10.37311/ijpe.v1i2.11143
Priyaputranti, A. S., Rahmawati, Sp.FRS., Apt., D. F., & Yasin, N. M. (2023). Gambaran Kepatuhan Penggunaan Obat Antituberkulosis Pada Pasien Tuberkulosis Paru Di Puskesmas Pahandut Kota Palangkaraya. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 13(3), 140–152. https://doi.org/10.22146/jmpf.83777
Qoyyima, D. U., Wuryanto, M. A., Ginandjar, P., Martini, M., Diponegoro, U., Diponegoro, U., Kulon, P. T., & Health, M. W. (2020). Gambaran karakteristik penderita tuberkulosis dengan diabetes mellitus dengan lama pengobatan tuberkulosis paru > 6 bulan. Jurnal Kesehatan Masyarakat, 8(4), 458–463. https://doi.org/10.14710/jkm.v8i4.27349
Ratnasari, N. Y. (2020). Faktor resiko kejadian multi drug resistant tuberculosis (MDR TB) di Surakarta, Jawa Tengah. Jurnal Penelitian Kesehatan Suara Forikes, 11(1), 67–72.
Sari, I. D., Mubasyiroh, R., & Supardi, S. (2017). Hubungan Pengetahuan dan Sikap dengan Kepatuhan Berobat pada Pasien TB Paru yang Rawat Jalan di Jakarta Tahun 2014. Media Penelitian Dan Pengembangan Kesehatan, 26(4), 243–248. https://doi.org/10.22435/mpk.v26i4.4619.243-248
Soesanti, & Husen, A. H. (2022). Analisis Faktor Determinan Demografi Dengan Kejadian Tuberculosis Multidrug Resistant Tuberculosis (MDR-TB). Jurnal Nursing Update, 13(2), 42–47.
Sutrisna, M., & Elsi Rahmadani. (2022). Hubungan Usia dan Jenis Kelamin dengan TB MDR. Sehat Rakyat: Jurnal Kesehatan Masyarakat, 1(4), 370–376. https://doi.org/10.54259/sehatrakyat.v1i4.1168
WHO. (2016). Global tuberculosis report 2016. https://www.who.int/publications/i/item/9789241565394
WHO. (2017). Global tuberculosis report 2017. https://www.who.int/publications/i/item/9789241565516
WHO. (2019). Global tuberculosis report 2019. https://www.who.int/publications/i/item/9789241565714
WHO. (2021). Global tuberculosis report 2021. https://www.who.int/publications/i/item/9789240037021
WHO. (2022). Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
Yobeanto, N., & Setiawan, L. (2022). Pola Resistensi Kuman Mycobacterium Tuberculosis Terhadap Obat Anti Tuberkulosis Lini Pertama. 3(0), 1–17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maureen Mamesah, Billy J. Kepel, Nurdjannah Jane Niode

This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitted paper will be firstly reviewed by the editors to determine whether the paper meet the edition theme and submission guidelines. Papers which meet the theme and the guidelines will be assigned to selected reviewers for peer-reviews. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan is a double blind peer-reviewed journal which involves reviewers based on their experties relevant to the topic of the paper. Final decision of paper acceptance is solely decided by the editors according to reviewers' comment.
Plagiarism and self-plagiarism are prohibited. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan uses PlagiarismCheckerX and iThenticate to scan papers for detecting plagiarism. Thus, Appropriate citation and quotation should be used